CAS NO: | 314-13-6 |
规格: | ≥98% |
包装 | 价格(元) |
2g | 电议 |
5g | 电议 |
10g | 电议 |
25g | 电议 |
50g | 电议 |
Molecular Weight (MW) | 960.81 |
---|---|
Formula | C34H24N6O14S4.4Na |
CAS No. | 314-13-6 |
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent | |
Solubility (In vitro) | DMSO: 100 mg/mL (104.1 mM) |
Water: 100 mg/mL (104.1 mM) | |
Ethanol: <1 mg/mL | |
SMILES | [O-]S(C1=CC(S([O-])(=O)=O)=C2C=CC(/N=N/C3=CC=C(C4=CC=C(/N=N/C5=C(O)C6=C(N)C(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C6C=C5)C(C)=C4)C=C3C)=C(O)C2=C1N)(=O)=O.[Na+].[Na+].[Na+].[Na+] |
Synonyms | Direct Blue 53 |
In Vitro | In vitro activity: Evans Blue is found to be inhibiting DNA binding of NF-κB at a low concentration of 100 μM. It has proven over the years to be a dependable stain for microscopic determination of cell death. Evans Blue is also a known blocker of a subset of a-amino-3-hydroxy-5-methyl-isoxazole/kainate receptors (IC50=355 nM) for the subunit combination GluR1,2. Evans blue is the first known δ-subunit-specific antagonist of ENaC and activates large-conductance Ca2+-activated K+ channels in sheep bladder myocytes and cultured endothelial cells of human umbilical veins. Kinase Assay: Cell Assay: |
---|---|
In Vivo | Evans blue pretreatment could inhibit the mast cells degranulation and that may be the main mechanism for prevent animals from C48/80-triggered anaphylaxis and systemic inflammation. Evans blue modulates the non-N-methyl-d-aspartate receptor in rat thalamic neurons, blocks the P2X-purinergic receptor in rat vas deferens, and inhibits the glutamate transporter in rat brain synaptic vesicles. |
Animal model | CD hairless rats |
Formulation & Dosage | Dissolved in saline; 100 mg/kg; i.p. |
References | Bioorg Med Chem Lett. 2004 Dec 20;14(24):6123-7; J Pharmacol Exp Ther. 2005 Nov;315(2):965-9. |